Drug Research
FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go global” and promote the innovation and development of industry
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the...
Drug Research
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry
As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually clear, which provides broad space for the development of pharmaceutical enterprises. The CRO & CMO industry, an important part of the R&D industry chain...
News
Continuing the Resplendence with 20 Years Glory, CPhI China Welcomes the Golden Year of Chinese Pharma
As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020 will take place at Shanghai New International Expo Centre (SNIEC) June 22-24, 2020. The exhibition will reach a scale of 210,000m2, facilitate...
Drug Research
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets
IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers of antibody-based therapeutics for modulation of gamma delta T-cells.
The agreement is to generate and optimise...
Drug Research
BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development
BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, announced a strategic collaboration to co-develop therapies. The organizations will form co-owned,...
Drug Research
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf
The new manufacturing facility is designed to have advanced features based on the efficiency of the existing facilities and requires approximately JPY10bn ($90m) in construction costs
Japanese pharmaceutical firm Astellas has unveiled plans to construct the Third Fermentation Building as...
News
PharmaLex strengthens Healthcare Compliance services
PharmaLex Group, one of the most experienced and most successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, have completed the merger with CompliMed in the United Kingdom.
CompliMed is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read